Renoprotective Effect of the Addition of Losartan to Ongoing Treatment with an Angiotensin Converting Enzyme Inhibitor in Type-2 Diabetic Patients with Nephropathy-Reference-Cited by-同舟云学术

Renoprotective Effect of the Addition of Losartan to Ongoing Treatment with an Angiotensin Converting Enzyme Inhibitor in Type-2 Diabetic Patients with Nephropathy

Published:2007 Issue:10 Volume:30 Page:929-935
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

ABE Hirohiko,MINATOGUCHI Shinya,OHASHI Hiroshige,MURATA Ichijiro,MINAGAWA Taro,OKUMA Toshio,YOKOYAMA Hitomi,TAKATSU Hisato,TAKAYA Tadatake,NAGANO Toshihiko,OSUMI Yukio,KAKAMI Masao,TSUKAMOTO Tatsuo,TANAKA Tsutomu,HIEI Kunihiko,FUJIWARA Hisayoshi

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference28 articles.

1. 1. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 1997; 51: 1-15.

2. 2. Navi SG, de Zeeuw D: Titrating for antiproteinuric effect; the clue to renoprotection? J Hum Hypertens 1996; 10: 669-673.

3. 3. William JD, Coles GA: Proteinuria—a direct cause of renal morbidity? Kidney Int 1994; 45: 443-450.

4. 4. Peterson JC, Adler S, Burkart J, et al: Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med 1995; 123: 754-762.

5. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

2. Efficacy and safety of dual blockade of the renin-angiotensin-aldosterone system in diabetic kidney disease: A meta-analysis;Diabetic Nephropathy;2023-06-01

3. Efficacy and safety of dual vs single renin–angiotensin–aldosterone system blockade in chronic kidney disease;Medicine;2021-09-03

4. Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2021-05-06

5. Comparative efficacy and safety of oral or transdermal opioids in the treatment of knee or hip osteoarthritis: a systematic review and Bayesian network meta-analysis protocol;BMJ Open;2018-10